These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20609411)

  • 1. Biochemical target isolation for novices: affinity-based strategies.
    Sato S; Murata A; Shirakawa T; Uesugi M
    Chem Biol; 2010 Jun; 17(6):616-23. PubMed ID: 20609411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tools and methodologies capable of isolating and identifying a target molecule for a bioactive compound.
    Sakamoto S; Hatakeyama M; Ito T; Handa H
    Bioorg Med Chem; 2012 Mar; 20(6):1990-2001. PubMed ID: 22264760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polyproline-rod approach to isolating protein targets of bioactive small molecules: isolation of a new target of indomethacin.
    Sato S; Kwon Y; Kamisuki S; Srivastava N; Mao Q; Kawazoe Y; Uesugi M
    J Am Chem Soc; 2007 Jan; 129(4):873-80. PubMed ID: 17243824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific affinity extraction method for small molecule-binding proteins.
    Mano N; Sato K; Goto J
    Anal Chem; 2006 Jul; 78(13):4668-75. PubMed ID: 16808480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Target identification of bioactive compounds.
    Tashiro E; Imoto M
    Bioorg Med Chem; 2012 Mar; 20(6):1910-21. PubMed ID: 22104438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomic methods for drug target discovery.
    Sleno L; Emili A
    Curr Opin Chem Biol; 2008 Feb; 12(1):46-54. PubMed ID: 18282485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determining the mode of action of bioactive compounds.
    Azad MA; Wright GD
    Bioorg Med Chem; 2012 Mar; 20(6):1929-39. PubMed ID: 22300885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seeing small molecules in action with bioorthogonal chemistry.
    Raghavan AS; Hang HC
    Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Photo-induced oxidative cross-linking as a method to evaluate the specificity of protein-ligand interactions.
    Lin HJ; Kodadek T
    J Pept Res; 2005 Feb; 65(2):221-8. PubMed ID: 15705166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins.
    Sparks AB; Hoffman NG; McConnell SJ; Fowlkes DM; Kay BK
    Nat Biotechnol; 1996 Jun; 14(6):741-4. PubMed ID: 9630982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the cellular targets of bioactive small organic molecules using affinity reagents.
    Leslie BJ; Hergenrother PJ
    Chem Soc Rev; 2008 Jul; 37(7):1347-60. PubMed ID: 18568161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new generation of protein display scaffolds for molecular recognition.
    Hosse RJ; Rothe A; Power BE
    Protein Sci; 2006 Jan; 15(1):14-27. PubMed ID: 16373474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immuno-chemo-proteomics method for drug target deconvolution.
    Saxena C; Zhen E; Higgs RE; Hale JE
    J Proteome Res; 2008 Aug; 7(8):3490-7. PubMed ID: 18590316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Target class strategies in mass spectrometry-based proteomics.
    Opiteck GJ; Scheffler JE
    Expert Rev Proteomics; 2004 Jun; 1(1):57-66. PubMed ID: 15966799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of molecular targets of natural products by mass spectrometry.
    Cheng KW; Wong CC; Wang M; He QY; Chen F
    Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Towards high-throughput characterization of small molecule mechanisms of action.
    Luesch H
    Mol Biosyst; 2006 Dec; 2(12):609-20. PubMed ID: 17216042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting protein druggability.
    Hajduk PJ; Huth JR; Tse C
    Drug Discov Today; 2005 Dec; 10(23-24):1675-82. PubMed ID: 16376828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.